There should be “more funding on the way,” according to Singlepoint CEO Greg Lambrecht, who discussed the acquisition in a recent episode of MoneyTV with Donald Baillargeon.
Marijuana Industry
Singlepoint, Inc. (SING) CEO Discusses Elizabeth Warren’s Cannabis Banking Proposal on MoneyTV with Donald Baillargeon
Before the opening bell, Singlepoint, Inc. (OTC: SING) was announced as a featured company on this week’s episode of MoneyTV with Donald Baillargeon.
Cannabis Biotechs Taking Leading Stance in Global Marijuana Market
Medical marijuana has among the highest values in the broader marijuana space, and as with any burgeoning industry, savvy investors are looking for evidence of the market’s core value.
At ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF), Medicinal Cannabinoid Quality and Safety are Founding Principles
Ken Clement, the founder of ABcann, with his wealth of experience and knowledge, had observed the variability in consistency and potency of cannabis that was currently available.
Medical Cannabis Companies Leverage Biosynthesis to Boost Drug Development
The future of cannabinoid-based medicine hinges on such innovations which is: the ability to produce cannabinoids identical to those found in nature in a safe, consistent and economical fashion to advance cannabis-based drug development.
Pot is the new alcohol
Pot is what alcohol used to be. It’s an industry ready to take off, but one that’s still finding its way , and one whose progress is not exactly encouraged by the federal government. It’s a little bit like Prohibition 2.0.
Singlepoint, Inc. (SING) Singles Out Three More Reasons for Marijuana Mills to have Bank Accounts
Singlepoint, Inc. (OTC: SING) welcomed the recent request to the Financial Crimes Enforcement Network (FINCEN), by 10 senators, for further guidance ‘to financial institutions on their ability to provide services, specifically to indirect businesses that do nothing more than provide services to the state-sanctioned marijuana industry’.
India Globalization Capital, Inc. (NYSE: IGC) Preparing to Bring Cannabis Combo Therapy for Alzheimer’s Disease to Trials
India Globalization Capital, Inc. (NYSE MKT: IGC) is racing ahead with its preparation of medical trials for four drug candidates that treat a variety of debilitating conditions.
An Overview of International Markets for Canadian Cannabis Companies
As more countries begin to allow some form legalization, opportunities arise for Canadian companies to expand their business. It’s hard to ignore the fact that the boom of Canadian stocks as the country prepares for legal recreational cannabis use has been felt on a global scale.
Alzheimer’s Disease: Cannabis Formulation Shows Promise
Currently, India Globalization Capital (IGC) is the only publicly traded pharmaceutical cannabis stock that addresses Alzheimer’s disease, which positions the company with a first-mover advantage in phytocannabinoid-based combination therapy.
PotNetwork Holding (POTN) Subsidiary Secures More Than $200,000 in Sales at Recent Trade Show
Diamond CBD Sales, a subsidiary of PotNetwork Holding, Inc. (OTC: POTN), attained more than $200,000 in sales at the Big Industry Trade Show in New York on August 10-11.
Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Technology Targets Many Massive Markets
The innovative biotech has developed a lipid-based system that delivers bioactive compounds more efficiently.
Copy of InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Builds Moat around Proprietary Biosynthesis Technology
If you have any doubt that InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is on the right track as it moves to protect its biosynthesis technology for cannabinoids, then a word from a famed figure may make you change your mind.
Cannabinoid Consumer Market Booming as CBD Enjoys Growth in Public Sentiment
As the cannabis industry continues to flourish, many publicly traded companies are finding ample opportunities to thrive.